InsidersTradesSigma
Track the 티앤알바이오팹 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 티앤알바이오팹 has logged 2 public disclosures. Market capitalisation: €110.1bn. The latest transaction was disclosed on 3 July 2026 (Other). Among the most active insiders: 윤원수. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
티앤알바이오팹 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing bio-printing technologies and solutions for regenerative medicine.